Effect of Almonds on Immune Strength and Response to Flu Vaccination in Overweight Older Men and Postmenopausal Women: A Randomized Controlled Study

NCT05031663 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2025-12-09

No results posted yet for this study

Summary

This research study will test the effects of almonds on immune functions and immune response to influenza vaccine in overweight middle-aged men and postmenopausal women

Conditions

Interventions

DIETARY_SUPPLEMENT

Almond group

Participants in the Almond group will receive 15% of their daily energy intake in the form of almonds as a snack

DIETARY_SUPPLEMENT

Control Group

The control group will continue their usual diet but will completely avoid almonds and restrict other nuts to less than 2 servings per week

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Joan Sabate, DrPh · Loma Linda University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-12
Primary Completion
2023-05-10
Completion
2023-05-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05031663 on ClinicalTrials.gov